Importantly, R273 mutants were associated with significantly shorter disease-specific overall survival than R175 mutants (Fig. 1e), regardless of patient age, tumor location or presence of KRAS mutations (Fig. 1f and Supplementary Table 1). The gene discussed is KRAS; the disease is neoplasm.